Key details
Professor Derek Moore
Pro-Vice-Chancellor (Education, Health and Human Sciences) and Executive Dean
Professor Moore joined the Faculty of Education, Health & Human Sciences as Pro-Vice-Chancellor in January 2018. He is also an Executive Dean.
Prior to joining Greenwich, Derek was Head of the School of Psychology at the University of Surrey (2015-2018) and before this was Director of the Institute for Research in Child Development at the University of East London (2007-2015) where he also was Director the institutional REF 2014 submission.
Earlier in his career, he was a lecturer and Reader at UEL from 1995 to 2007 and prior to this was a postdoctoral researcher at the Institute of Psychiatry, Kings College, City University, and the Tavistock Clinic. Derek has a PhD from University College London, and is also trained as a bio-medical statistician.
Derek has undertaken many multidisciplinary studies of child development across the pre-natal to adolescent periods, looking at the effects of a range of risk factors associated with socio-economic deprivation and neuro-developmental difficulties. His aim is to generate better theoretical models that facilitate more effective and targeted interventions. His research has been funded by ESRC, NiH, NIHR, the Wellcome trust, and the Nuffield foundation.
Responsibilities within the university
Recognition
Derek was previously a committee member of the Association of Heads of Psychology Departments.
He is a member of the All-Party-Parliamentary-Group for Conception to Age 2, and has been a research advisor for a number of charities and NHS trusts. He is also an external REF reviewer
Research / Scholarly interests
- Relationship between social and cognitive development from infancy to adolescence
- Assessment of infants at risk for developmental difficulties
- Effects of in utero exposure to recreational drugs
- Impact of socio-economic-status on early neurocognitive development
- Neuro-developmental disabilities
- Feasibility of using mobile neuro-technology for infant screening and training
- Creation of new visualisation systems to model atypical development
- Impact of regeneration and community intervention on health and wellbeing
Key funded projects
Grant awarded
- 2012-2016 NIHR Public Health. £1,991,000 (Co-I)ORiEL study: Evaluating the impact of urban regeneration and the Olympics on health and health inequalities in adolescents and their parents
with Cummins (PI, QMUL), Stansfeld (QMUL), Renton (UEL), Petticrew (LSHTM) et al. - 2012-2015Wellcome Trust £168,626 (Co-I) 50k to IRCD Extension of Well London Cluster Randomised Trial. Co-I with Renton (UEL) , Petticrew (LSHTM), Hayes (LSHTM), Clow (U West) et al.
- 2010-2013 Nuffield Foundation £166,000 (PI) TALBY study. Using new technologies (eye-tracking) to engage parents from disadvantaged areas in the assessment of their babies. PI with Tomalski, Kushnerenko, Johnson, Karmiloff-Smith (Birkbeck)
- 2011-2012Nuffield Foundation £25,000 (PI) iSTARS study: a pilot study using eye-tracking technology to deliver gaze-contingency training in children's centres. PI with Tomalski, Kushnerenko (UEL) Wass, Johnson, Karmiloff-Smith (Birkbeck)
Recent publications
Clark, C, et al (2017) An Olympic Legacy? Does the urban regeneration associated with the London 2012 Olympic Games impact on adolescent mental health?" American Journal of Epidemiology kwx205, https://doi.org/10.1093/aje/kwx205
Singer, L. T., Moore, D. G., Min, M. O., Goodwin, J., Turner, J. J., Fulton, S., & Parrott, A. C. (2016). Motor delays in MDMA (ecstasy) exposed infants persist to 2years. Neurotoxicology and Teratology, 54, 22-28.
Ballieux, H., Wass, S. V., Tomalski, P., Kushnerenko, E., Karmiloff-Smith, A., Johnson, M. H., & Moore, D. G. (2016). Applying gaze-contingent training within community settings to infants from diverse SES backgrounds. Journal of Applied Developmental Psychology, 43, 8-17.
Ballieux, H., Tomalski, P., Kushnerneko, E., Johnson, M. H., Karmiloff‐Smith, A., & Moore, D. G. (2016). Feasibility of Undertaking Off‐Site Infant Eye‐Tracking Assessments of Neuro‐Cognitive Functioning in Early‐Intervention Centres. Infant and Child Development, 25(1), 95-113.
Singer, L. T., Moore, D. G., Min, M. O., Goodwin, J., Turner, J. J., Fulton, S., & Parrott, A. C. (2015). Developmental outcomes of 3, 4‐methylenedioxymethamphetamine (ecstasy)‐exposed infants in the UK. Human Psychopharmacology: Clinical and Experimental, 30(4), 290-294.
Turner, J. J., Parrott, A. C., Goodwin, J., Moore, D. G., Fulton, S., Min, M. O., & Singer, L. T. (2014). Psychiatric profiles of mothers who take Ecstasy/MDMA during pregnancy: Reduced depression 1 year after giving birth and quitting Ecstasy. Journal of Psychopharmacology, 28(1), 55-61. doi: 10.1177/0269881113515061
Phillips, G., Bottomley, C., Schmidt, E., Tobi, P., Lais, S., Yu, G., ... Moore, D. G... & Renton, A. (2014). Well London Phase-1: results among adults of a cluster-randomised trial of a community engagement approach to improving health behaviours and mental well-being in deprived inner-city neighbourhoods. Journal of Epidemiology and Community Health doi:10.1136/jech-2013-202505
Singer, L., Moore, D. G., Min, M. O., Goodwin, J., Turner, J. J., Fulton, S., & Parrott, A. C. (2014). Longitudinal outcomes of MDMA (Ecstasy)-exposed infants in the United Kingdom. Drug & Alcohol Dependence, 140, e210.
Smith, N. R., Lewis, D. J., Fahy, A., Thompson, C., Clark, C., Stansfeld, S., ... & Petticrew, M. (2014). Changes in physical activity in East London's adolescents following the 2012 Olympic Games: findings from the prospective Olympic Regeneration in East London (ORiEL) cohort study. Journal of Epidemiology and Community Health, 68(Suppl 1), A23-A24.